Champions Oncology (CSBR) Payables (2011 - 2026)

Champions Oncology has reported Payables for 16 years, with the latest figure at $6.9 million in Q2 2026.

• On a quarterly basis, Payables rose 62.5% year-over-year to $6.9 million in Q2 2026; TTM through Apr 2026 was $6.9 million, a 62.5% increase from a year earlier, with the FY2026 full-year figure at $6.9 million, up 62.5% from the prior year.
• Payables was $6.9 million for Q2 2026 at Champions Oncology, up from $5.7 million in the prior quarter.
• The five-year high for Payables was $6.9 million in Q2 2026, with the low at $2.5 million in Q3 2022.
• Average Payables over 5 years is $4.8 million, with a median of $4.8 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Payables jumped 127.0% in 2023, then fell 26.76% in 2025.
• Over 5 years, Payables stood at $4.6 million in 2022, then retreated by 1.5% to $4.5 million in 2023, then climbed by 7.01% to $4.9 million in 2024, then gained by 23.47% to $6.0 million in 2025, then increased by 15.18% to $6.9 million in 2026.
• The last three Payables figures came in at $6.9 million (Q2 2026), $5.7 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.